More Health: For People & Animals
Collaboration to fight NCDs
70 percent of global deaths are attributable to NCDs and which particularly impact people in low- and middle-income countries.
Search
223 Result(s)
Clinical Collaborations
Collaboration at our Heart
Our collaborative approach is grounded in mutual trust, shared goals and a passion for leading science.
GPP
Generalized pustular psoriasis: The value of collaboration
Dr Emmanuelle Clerisme-Beaty, Boehringer Ingelheim’s Therapeutic Area Inflammation Head of Medicine, in conversation with Dr Bruce Strober MD, PhD
Meet our team
How collaboration is driving innovation at Boehringer Ingelheim Animal Health
In conversation with Dr. Megan Grether, Global Head of Business Development & Licensing, Boehringer Ingelheim Animal Health.
More Health: For People & Animals
Tackling NCDs through innovation AND collaboration
Non-communicable diseases are a significant medical, humanitarian and socio-economic issue. Rapid innovation and holistic approaches help us tackle them.
January 18, 2022
Collaboration with MabGenesis to discover and develop novel monoclonal antibodies in canine
April 14, 2021
Expansion of Collaboration with MD Anderson to Explore KRAS and TRAILR2 Compounds in Lung Cancer
January 12, 2021
Collaboration with Enara Bio on Cancer Immunotherapies
September 09, 2021
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration
March 30, 2017
Novozymes and Boehringer Ingelheim announce Strategic Collaboration in Probiotics for Poultry Hatcheries
October 14, 2020
Expanded alliance with OBT advances cancer immunology pipeline
September 17, 2020
Boehringer Ingelheim and Mirati Therapeutics Announce Clinical Collaboration to Study BI 1701963, a SOS1::pan-KRAS Inhibitor in Combination with MRTX849, a KRAS G12C Selective Inhibitor
February 19, 2024
The Sleip app uses artificial intelligence (AI) to provide objective analysis of a horse’s movement with just a smartphone.
September 16, 2021
Clinical collaboration with Amgen on KRAS
May 17, 2018
Boehringer Ingelheim Expert Forum on Farm Animal Well-Being 2018
Fostering Science
Research Beyond Borders
Read more about how our Research Beyond Borders team is uncovering new ideas and new science.
More Green
Responsible Supply Chain Management
Boehringer Ingelheim procures its raw materials, intermediates, packaging materials, technical components and services from international suppliers.
March 16, 2021
Collaboration with the LIBD to Develop Centrally Acting COMT Inhibitors
October 25, 2021
Boehringer Ingelheim increases commitments to sustainable development, investing in health innovation and collaborations to expand access and improve healthcare for 50 million people in vulnerable communities by 2030
October 27, 2021
Mental health collaboration with King’s College London
December 07, 2020
Collaboration with Proxygen on Molecular Glue Degraders
March 29, 2022
Boehringer Ingelheim selects Veeva Development Cloud worldwide to bring innovative therapies to patients faster
September 27, 2021
Boehringer Ingelheim and Invetx announce strategic collaboration
September 11, 2020
Boehringer Ingelheim and Click Therapeutics Enter into Collaboration to Develop and Commercialize CT-155, a Novel Prescription Digital Therapeutic to Aid in the Treatment of Schizophrenia
March 01, 2021